A Study of Telemonitoring in Cancer Patients

NARecruitingINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

April 4, 2023

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2024

Conditions
Cancer
Interventions
DEVICE

remote patient monitoring

"Cureety is a digital telemonitoring platform, specifically designed to monitor signs and symptoms of disease progression and AEs in cancer patients. The digital tool is adaptable to specific treatments and disease settings. The platform collects various data including treatment delays, dose reductions, quality of life and safety data. In terms of safety, once configured for the treatment and disease setting, the patient responds to an electronic PRO (ePRO) questionnaire based on the NCI-CTCAE version (v)5.0.10 Depending on the responses, an algorithm classifies patients as either correct, compromised, state to be monitored, or critical state. Depending on the classification, patients are notified of the actions to be taken."

Trial Locations (1)

91640

RECRUITING

Centre Hospitalier de Bligny, Briis-sous-Forges

Sponsors
All Listed Sponsors
collaborator

Exystat

OTHER

collaborator

Cureety

INDUSTRY

collaborator

Pharmaspecific

UNKNOWN

collaborator

ProPens

UNKNOWN

lead

Centre Hospitalier de Bligny

OTHER